Aignostics

About:

Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research.

Website: http://www.aignostics.com

Twitter/X: aignostics

Top Investors: Wellington Partners, IBB Ventures, HTGF | High-Tech Gruenderfonds, Boehringer Ingelheim Venture Fund, Future Capital

Description:

Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research. Its “explainable” AI overcomes the “black-box” limitations of conventional AI. Based on their patented technology for reverse-engineering the black box, they render diagnostic results explainable in the form of precise heatmaps and image overlays. These heatmaps allow pathologists to quickly verify the results of the AI, which is crucial, as the pathologist is ultimately responsible for the diagnosis. The company was founded in 2018 and is headquartered in Berlin, Germany.